Survival of Stomach Cancer Cases in Khon Kaen, Thailand 2000-2012

  • Published : 2016.06.01


Background: Stomach cancer is an aggressive malignancy that is difficult to detect at an early stage and therefore is characterized by poor survival rates. Over the last two decades, there has been no report of gastric cancer survival in Khon Kaen province, Thailand. The aim of this retrospective cohort study was to provide up-to-date information about the survival of gastric cancer patients in this province. Materials and Methods: Data from Khon Kaen population-based cancer registry, Faculty of Medicine, Khon Kaen University were newly obtained on 650 patients who were diagnosed with stomach cancer during the period 1 January, 2000 to 31 December, 2012. These were then followed up until death or the end of the study (31 December 2014). We calculated the observed survival with the actuarial life table method, and relative survival, defined as the ratio of observed survival in the group of the stomach cancer patients to the expected survival in the entire Thai population from the estimated generation life tables for Thailand of five-year birth cohorts from 1900 - 2000. Results: The 5 year observed and 5 year relative survival rates were 17.2 % (95% CI: 13.54-21.14) and 18.2 % (95% CI: 14.3-22.4), respectively. The highest 5 year relative survival rates were demonstrated among patients aged 45-65, with stage I or II lesions, with adenocarcinomas, with a body of stomach location, well differentiated and receiving surgery and/or chemotherapy. Conclusions: The observed and relative survival rates were close to each other. Our findings provide basic information beneficial to development of an effective treatment system and appropriately improved population-based cancer registration.



  1. Bae JM, Won YJ, Jung KW, et al (2002). Survival of Korean cancer patients diagnosed in 1995. Cancer Res Treat, 34, 319-25.
  2. Brenner H, Hakulinen T (2001). Long-term cancer patient survival achieved by the end of the 20th century: most up-todate estimates from the nationwide Finnish cancer registry. British J Cancer, 85, 367.
  3. Brenner H, Hakulinen T (2005). Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. British J Cancer, 92, 576-9.
  4. Che Y, You J, Zhou S, et al (2014). Comparison of survival rates between chinese and thai patients with breast cancer. Asian Pac J Cancer Prev, 15, 6029.
  5. Cho H, Howlader N, Mariotto AB, Cronin KA (2011). Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, NCI, Technical Report, 2011, 1.
  6. De Angelis R, Sant M, Coleman MP, et al (2014). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 a population-based study. Lancet Oncol, 15, 23-34.
  7. Dickman PW, Hakulinen T, Luostarinen T, et al (1999). Survival of cancer patients in Finland 1955-1994. Acta Oncol, 38, 1-103.
  8. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
  9. Gondos A, Brenner H, Wabinga H, Parkin DM (2005). Cancer survival in Kampala, Uganda. British J Cancer, 92, 1808-12.
  10. Hansson LE, Sparen P, Nyren O (1999). Survival in stomach cancer is improving: results of a nationwide populationbased Swedish study. Ann Surg, 230, 162.
  11. Heise K, Bertran E, Andia ME, Ferreccio C (2009). Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol, 15, 1854.
  12. Houterman S, Janssen Heijnen MLG, van de Poll Franse LV, et al (2006). Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Annals of Oncology, 17(4), 709-712.
  13. Hundahl SA, Phillips JL, Menck HR (2000). The National Cancer Data Base report on poor survival of US gastric carcinoma patients treated with gastrectomy. Cancer, 88, 921-32.<921::AID-CNCR24>3.0.CO;2-S
  14. Imsamran W, et al (2015). Cancer in Thailand (Vol. VIII, 2010-2012). National Cancer Institute, Thailand.
  15. Innos K, Baburin A, Aareleid T (2014). Cancer patient survival in Estonia 1995-2009: Time trends and data quality. Cancer Epidemiol, 38, 253-8.
  16. Jensen OM (1991). Cancer registration: principles and methods (Vol. 95). IARC.
  17. Jung KW, Yim SH, Kong HJ, et al (2007). Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci, 22, 5-10.
  18. Prasartkul P, Rakchanyaban U (2002). Estimated generation life tables for Thailand of five-year birth cohorts: 1900-2000.
  19. Rachet B, Maringe C, Nur U, et al (2009). Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol, 10, 351-69.
  20. Sankaranarayanan R, Swaminathan R, Brenner H, et al (2010). Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol, 11, 165-173.
  21. Sant M, Aareleid T, Berrino F, et al (2003). EUROCARE-3: survival of cancer patients diagnosed 1990-94 results and commentary. Ann Oncol, 14, 61-118.
  22. Sriamporn S, Black RJ, Sankaranarayanan R, et al (1995). Cancer survival in Khon Kaen Province, Thailand. Int J Cancer, 61, 296-300.
  23. Suwanrungruang K, Wiangnon S, Sriamporn S, et al (2006). Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985-2004. Asian Pac J Cancer Prev, 7, 623-6.
  24. Tsukuma H, Ajiki W, Ioka A, et al (2006). Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Japanese J Clin Oncol, 36, 602-7.
  25. Vatanasapt V, Sriamporn S, Kamsa-ard S, et al (1998). Cancer survival in Khon Kaen, Thailand. IARC Scientific Publications, 123-34.
  26. Wang J, Yu JC, Kang WM, Ma ZQ (2012). Treatment strategy for early gastric cancer. Surgical Oncol, 21, 119-23.
  27. Wang SJ, Emery R, Fuller CD, et al (2007). Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer, 10, 153-8.
  28. Xiang YB, Jin F, Gao YT (2010). Cancer survival in Shanghai, China, 1992-1995. IARC Scientific Publications, 162, 55-68.
  29. Zhang SY, Zhang SQ, Nagaraju GP, El-Rayes BF (2015). Biomarkers for personalized medicine in GI cancers. Molecular Aspects Med.

Cited by

  1. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up vol.46, pp.1, 2017,